TotalMarketCap

Eli Lilly & Co

LLYNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.289 T

$1,369.96 -3.39%

Close of 6 Nov 2026

As of 6 Nov 2026, Eli Lilly & Co (LLY) has a market capitalization of $1.29T. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$65.2B

#61 by revenue

Earnings

$20.6B

#22 by earnings

Shares outstanding

940,745,031

Latest filing cover page

P/E ratio

62.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #1Eli Lilly & CoLLY$1.29T
  2. #2Johnson & JohnsonJNJ$656.3B
  3. #3AbbVieABBV$510.3B
  4. #4Merck & Co.MRK$362.2B
  5. #5NovartisNVS$309.0B

What if Eli Lilly & Co were worth as much as…

Open the what-if tool →

Gold $28.2T

$30,015.44

Per share 21.9× higher

Bitcoin $1.53T

$1,624.08

Per share 1.19× higher

Apple $5.02T

$5,331.71

Per share 3.89× higher

Or at a round number

$2.00T$5.00T$10.0T$20.0T

Where these numbers come from

Share counts and financials for Eli Lilly & Co are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.